Since 1934, it has been known that individuals suffering from such diseases as scarlet fever, diphtheria, tuberculosis, arthritis, malignant tumours and lymphogranulomas exhibit an elevation of copper in their blood plasma. Since then, the list of maladies bringing about such elevation has been extended to fever, wounds, ulcers, pain, seizures, cancers, carcinogenesis, diabetes, cerebrovascular and cardiovascular diseases, and irradiation and tissue stresses, including restricted blood flow. This suggests that this redistribution of copper in the body has a general role in responding to physiological, disease, or injury stress. On the other hand, the elevation of copper in the affected organ has led some to postulate that it was this excess of copper that caused the disease. Nonetheless, this elevation of copper in diseased states is suggested to account for the natural synthesis of copper dependent regulatory proteins and enzymes in the body required for biochemical responses to stress. It may be that these natural copper complexes expedite the relief of stress and the repair of tissues. Thus, it appears that in addition to the anti bacterial and anti fungal activity of inorganic copper compounds as recognized by the ancients, metallo organic complexes of copper have medicinal capabilities that are fundamental to the healing process itself.
While research into medical cannabis is still limited due to restrictions preventing scientists from obtaining the drug, recent studies have explored some therapeutic aspects of medical marijuana. For example, a 2015 study found that cannabis could be effective in treating schizophrenia. Research has also shown that it can help heal broken bones , stop severe seizures , and even cure migraines. And one 2014 study suggested that cannabis might be effective in targeting brain tumors, though far more research is needed to replicate those results.